Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001641172-25-020764
Filing Date
2025-07-24
Accepted
2025-07-23 21:58:29
Documents
20

Document Format Files

Seq Description Document Type Size
1 S-1 forms-1.htm S-1 1390070
2 EX-5.1 ex5-1.htm EX-5.1 13121
3 EX-23.1 ex23-1.htm EX-23.1 4315
4 EX-23.2 ex23-2.htm EX-23.2 4941
5 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 27184
6 GRAPHIC formdrs_001.jpg GRAPHIC 15567
7 GRAPHIC ex5-1_001.jpg GRAPHIC 10144
8 GRAPHIC forms-1fin_002.jpg GRAPHIC 2471
9 GRAPHIC forms-1fin_001.jpg GRAPHIC 40816
10 GRAPHIC ex_23-1.jpg GRAPHIC 7086
  Complete submission text file 0001641172-25-020764.txt   1673088

Data Files

Seq Description Document Type Size
22 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 7898
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-288911 | Film No.: 251144370
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)